Exogenous administration of neurotrophins using implantable mini-pumps has been shown to improve the survival of SGNs in animal deafness models [17–24] with the SGN peripheral fibres becoming larger and more numerous compared to untreated cochleae [20, 25]. The gene discussed is BDNF; the disease is deafness.